Technology,
Health Care & Hospital Law
Dec. 9, 2022
Neuralink’s problems may be beginning for AI medical device industry
Some major concerns are the reliability of the algorithms, privacy protection and unwanted third party interference, which are issues the Food and Drug Administration is evaluating.
Recent reports that Neuralink Corp. is under a federal investigation over possible cruelty to animals raises questions about what other regulatory issues and litigation threats the emerging artificial intelligence medical device industry faces.
Lisa C. Ikemoto, Martin Luther King Jr. Professor at UC Davis School of Law, wrote in an email that there are many potential issues with the AI medical device sector. Some major concerns are the rel...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In